Become a Member
Dark Mode
Become a Member
Members Only
Latest News
Special Projects
Neon
FIT
Webqoof
My Report
Brand Studio
Indian Diaspora
Entertainment
Opinion
World
Videos
Podcasts
Sports
Law
More
Gender
Climate Change
FAQs
Explainers
Graphic Novels
Education
Quint Lab
Business
Good News
Members' Opinion
Photos
Dark Mode
Become a Member
Home
Elections
Jobs
About Us
T&C
Privacy Policy
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
×
×
Serum Institute of India
FAQ | India's First Home-Grown HPV Vaccine Launched: How Much Will It Cost?
Man Sues SII, Bill Gates Over Death of Daughter Allegedly Due to Covishield
ADVERTISEMENT
FAQ | India’s First HPV Vaccine for Cervical Cancer: Why Do We Need It?
SII Chief Adar Poonawalla Hopes for a Global Treaty To Gear Up for Next Pandemic
Immunisation Panel Approves Use Of SII's Covovax For 12-17 Age Group: Report
Novovax's COVID-19 Vaccine Gets Emergency Use Nod From DCGI for Kids Aged 12-17
SII's Covovax Receives Emergency Use Approval for Adults, Children Over 12
Covovax Becomes 9th Vaccine To Receive WHO's Emergency Approval
SII to Launch COVID-19 Vaccine for Children in 6 Months: Adar Poonawalla
With Over 1.25 Billion Jabs in India, SII Seeks Full Approval for Covishield
Covishield Booster Dose: Expert Panel Seeks Local Trial Data for Approval
Serum Institute Seeks Approval for Covishield as Booster Dose From DGCI
FAQ | India's First Home-Grown HPV Vaccine Launched: How Much Will It Cost?
Man Sues SII, Bill Gates Over Death of Daughter Allegedly Due to Covishield
FAQ | India’s First HPV Vaccine for Cervical Cancer: Why Do We Need It?
SII Chief Adar Poonawalla Hopes for a Global Treaty To Gear Up for Next Pandemic
Immunisation Panel Approves Use Of SII's Covovax For 12-17 Age Group: Report
Novovax's COVID-19 Vaccine Gets Emergency Use Nod From DCGI for Kids Aged 12-17
ADVERTISEMENT
SII's Covovax Receives Emergency Use Approval for Adults, Children Over 12
With Over 1.25 Billion Jabs in India, SII Seeks Full Approval for Covishield
Covovax Becomes 9th Vaccine To Receive WHO's Emergency Approval
SII to Launch COVID-19 Vaccine for Children in 6 Months: Adar Poonawalla
Covishield Booster Dose: Expert Panel Seeks Local Trial Data for Approval
Serum Institute Seeks Approval for Covishield as Booster Dose From DGCI
Load More
